WEBULL
News
ZIMV
18.99
0.00%
0.00
ZimVie Inc Completes Acquisition by ARCHIMED
TipRanks · 10/20 18:36
ZimVie Inc. Delists from NASDAQ After ARCHIMED Acquisition
Reuters · 10/20 13:10
ZIMVIE ANNOUNCES COMPLETION OF ITS ACQUISITION BY ARCHIMED
Reuters · 10/20 13:00
Press Release: ZimVie Announces Completion of its Acquisition by ARCHIMED
Dow Jones · 10/20 13:00
Weekly Report: what happened at ZIMV last week (1013-1017)?
Weekly Report · 10/20 10:40
Weekly Report: what happened at ZIMV last week (1006-1010)?
Weekly Report · 10/13 10:44
Noteworthy Friday Option Activity: XOM, ZIMV, IBM
NASDAQ · 10/10 22:04
ZimVie Inc Stockholders Approve Acquisition by ARCHIMED
TipRanks · 10/10 21:02
ZimVie Shareholders Approve Acquisition By ARCHIMED Affiliate
NASDAQ · 10/10 13:44
ZimVie shareholders approve acquisitiion by ARCHIMED
TipRanks · 10/10 13:20
ZimVie Stockholders Approve Acquisition By ARCHIMED Affiliate; Merger Expected To Close On October 20
Benzinga · 10/10 13:17
ZIMVIE STOCKHOLDERS VOTE TO APPROVE ACQUISITION BY ARCHIMED
Reuters · 10/10 13:15
Press Release: ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
Dow Jones · 10/10 13:15
Weekly Report: what happened at ZIMV last week (0929-1003)?
Weekly Report · 10/06 10:40
ZimVie Inc Faces Legal Challenges Over Merger
Barchart · 10/04 16:14
ZimVie Inc. Files Amended Proxy Statement with SEC, Updates Details on Pending Merger with Zamboni Parent Inc
Reuters · 10/03 20:35
Weekly Report: what happened at ZIMV last week (0922-0926)?
Weekly Report · 09/29 10:41
Weekly Report: what happened at ZIMV last week (0915-0919)?
Weekly Report · 09/22 10:41
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
Barchart · 09/16 11:04
More
Webull provides a variety of real-time ZIMV stock news. You can receive the latest news about ZIMVIE INC through multiple platforms. This information may help you make smarter investment decisions.
About ZIMV
ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries.